Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases

Innovations in Clinical Neuroscience

Joanna P. MacEwan,PhD ; Seth Seabury,PhD ; Myrlene Sanon Aigbogun,MPH ; Siddhesh Kamat,MS,MBA ; Emma van Eijndhoven,MS,MA ; Clement Francois,PhD ; Crystal Henderson,PharmD,BCPP ; and Leslie Citrome,MD,MPH

关键词: Mental disorders, schizophrenia, bipolar disorder, major depressive disorder, pharmaceutical , disease burden, research and development, expenditures;   

学科分类：精神健康和精神病学

来源: Matrix Medical Communications, LLC

【 摘 要 】

The objectives of this study were to assess the level of private and public investment in research and development of treatments for schizophrenia and other mental disorders compared to other diseases in order to present data on the economic burden and pharmaceutical innovation by disease area, and to compare the level of investment relative to burden across different diseases.

【 授权许可】

Unknown